Monoclonal antibody therapy of diffuse cutaneous scleroderma with CAMPATH-1H.

A worker in a polyvinyl chloride factory with rapidly progressive diffuse cutaneous scleroderma was treated with the humanized monoclonal antibody (Mab) CAMPATH-1H. Treatment was followed by rapid and substantial improvement in skin score, which was maintained during followup without additional ther...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Isaacs, J, Hazleman, B, Chakravarty, K, Grant, J, Hale, G, Waldmann, H
Materialtyp: Journal article
Språk:English
Publicerad: 1996
Beskrivning
Sammanfattning:A worker in a polyvinyl chloride factory with rapidly progressive diffuse cutaneous scleroderma was treated with the humanized monoclonal antibody (Mab) CAMPATH-1H. Treatment was followed by rapid and substantial improvement in skin score, which was maintained during followup without additional therapy. The mode of action of CAMPATH-1H and its relationship to clinical improvement are discussed.